Literature DB >> 18194839

p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck.

Xiaolian Gu1, Philip J Coates, Linda Boldrup, Karin Nylander.   

Abstract

The transcription factor p63 is commonly over-expressed in squamous cell carcinomas of the head and neck (SCCHN). By microarray analysis of p63-siRNA-treated SCCHN cells we identified 127 genes whose expression relies on over-expression of p63. More than 20% of these genes are involved in cell motility. Chromatin immunoprecipitation and reporter assay revealed PAI-1 and AQP3 as direct p63 transcriptional targets. In addition to PAI-1, most of the key cell motility-related molecules are up-regulated by p63, such as MMP14 and LGALS1. Our findings indicate a contribution by p63 in cell invasion and migration, supporting an oncogenic role for p63 in SCCHN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18194839     DOI: 10.1016/j.canlet.2007.12.011

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  26 in total

1.  DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma.

Authors:  Karine Pallier; Aurélie Cazes; Laila El Khattabi; Cristina Lecchi; Marine Desroches; Claire Danel; Marc Riquet; Elizabeth Fabre-Guillevin; Pierre Laurent-Puig; Hélène Blons
Journal:  Tumour Biol       Date:  2011-10-11

2.  ΔNp63α represses anti-proliferative genes via H2A.Z deposition.

Authors:  Corrie L Gallant-Behm; Matthew R Ramsey; Claire L Bensard; Ignacio Nojek; Jack Tran; Minghua Liu; Leif W Ellisen; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2012-09-26       Impact factor: 11.361

3.  ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis.

Authors:  Lidia Rodriguez Calleja; Camille Jacques; François Lamoureux; Marc Baud'huin; Marta Tellez Gabriel; Thibaut Quillard; Debashish Sahay; Pierre Perrot; Jerome Amiaud; Celine Charrier; Regis Brion; Fernando Lecanda; Franck Verrecchia; Dominique Heymann; Leif W Ellisen; Benjamin Ory
Journal:  Cancer Res       Date:  2016-03-17       Impact factor: 12.701

Review 4.  New plays in the p53 theater.

Authors:  Yael Aylon; Moshe Oren
Journal:  Curr Opin Genet Dev       Date:  2010-11-04       Impact factor: 5.578

5.  ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers.

Authors:  Simon S McDade; Dennis J McCance; Kirtiman Srivastava; Adam Pickard; Stephanie G Craig; Gerard P Quinn; Shauna M Lambe; Jacqueline A James
Journal:  Clin Cancer Res       Date:  2018-05-08       Impact factor: 12.531

6.  Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.

Authors:  Danae Papadogianni; Nikolaos Soulitzis; Demetrios Delakas; Demetrios A Spandidos
Journal:  Tumour Biol       Date:  2013-11-11

Review 7.  Aquaporin-3 in the epidermis: more than skin deep.

Authors:  Wendy B Bollag; Lorry Aitkens; Joseph White; Kelly A Hyndman
Journal:  Am J Physiol Cell Physiol       Date:  2020-04-08       Impact factor: 4.249

Review 8.  Targeting EGFR resistance networks in head and neck cancer.

Authors:  Vladimir Ratushny; Igor Astsaturov; Barbara A Burtness; Erica A Golemis; Joshua S Silverman
Journal:  Cell Signal       Date:  2009-03-01       Impact factor: 4.315

9.  ΔNp63 regulates cell proliferation, differentiation, adhesion, and migration in the BL2 subtype of basal-like breast cancer.

Authors:  Paulina Orzol; Marta Nekulova; Jitka Holcakova; Petr Muller; Borivoj Votesek; Philip J Coates
Journal:  Tumour Biol       Date:  2016-01-29

10.  Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation.

Authors:  Simon S McDade; Alexandra E Henry; Geraldine P Pivato; Iwanka Kozarewa; Constantinos Mitsopoulos; Kerry Fenwick; Ioannis Assiotis; Jarle Hakas; Marketa Zvelebil; Nicholas Orr; Christopher J Lord; Daksha Patel; Alan Ashworth; Dennis J McCance
Journal:  Nucleic Acids Res       Date:  2012-05-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.